StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Down 99.7 % NYSE NAVB opened at $0.00 on Thursday. The company has a 50 day moving average of $0.04 and […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB opened at $0.00 on Thursday. Navidea Biopharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.17. The stock’s fifty day moving average price […]
Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB opened at $0.04 on Monday. The company has a 50-day simple moving average of $0.04 and a 200-day simple […]